Education
About Us
Working with TipRanks
Follow Us
BioNxt Solutions (BNXTF)
OTHER OTC:BNXTF
Total Valuation
BioNxt Solutions has a market cap or net worth of $43.02M. The enterprise value is ―.
Market Cap$43.02M
Enterprise Value―
Share Statistics
BioNxt Solutions has 113,402,110 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding113,402,110
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioNxt Solutions’s return on equity (ROE) is 1.46 and return on invested capital (ROIC) is 1638.92%.
Return on Equity (ROE)1.46
Return on Assets (ROA)-6.09
Return on Invested Capital (ROIC)1638.92%
Return on Capital Employed (ROCE)1.21
Revenue Per Employee14.89K
Profits Per Employee-308.92K
Employee Count25
Asset Turnover0.29
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioNxt Solutions is -6.50. BioNxt Solutions’s PEG ratio is -5.13.
PE Ratio-6.50
PS Ratio0.00
PB Ratio-8.57
Price to Fair Value-9.50
Price to FCF-19.07
Price to Operating Cash Flow-19.50
PEG Ratio-5.13
Income Statement
In the last 12 months, BioNxt Solutions had revenue of 372.25K and earned -7.72M in profits. Earnings per share was -0.08.
Revenue372.25K
Gross Profit372.25K
Operating Income-6.37M
Pretax Income-7.72M
Net Income-7.72M
EBITDA-6.48M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -3.25M and capital expenditures -84.32K, giving a free cash flow of -3.33M billion.
Operating Cash Flow-3.25M
Free Cash Flow-3.33M
Free Cash Flow per Share-0.03
Dividends & Yields
BioNxt Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.94
52-Week Price Change90.00%
50-Day Moving Average0.35
200-Day Moving Average0.25
Relative Strength Index (RSI)58.63
Average Volume (3m)4.10K
Important Dates
BioNxt Solutions upcoming earnings date is Jun 3, 2025, TBA Not Confirmed.
Last Earnings DateApr 23, 2025
Next Earnings DateJun 3, 2025
Ex-Dividend Date―
Financial Position
BioNxt Solutions as a current ratio of 0.11, with Debt / Equity ratio of -75.98%
Current Ratio0.11
Quick Ratio0.11
Debt to Market Cap0.10
Net Debt to EBITDA-0.70
Interest Coverage Ratio-6.11
Taxes
In the past 12 months, BioNxt Solutions has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioNxt Solutions EV to EBITDA ratio is -8.44, with an EV/FCF ratio of -10.19.
EV to Sales147.02
EV to EBITDA-8.44
EV to Free Cash Flow-10.19
EV to Operating Cash Flow-10.59
Balance Sheet
BioNxt Solutions has $80.06K in cash and marketable securities with C$5.61M in debt, giving a net cash position of $5.53M billion.
Cash & Marketable Securities$80.06K
Total DebtC$5.61M
Net Cash$5.53M
Net Cash Per Share$0.05
Tangible Book Value Per Share-$0.05
Margins
Gross margin is -111.89%, with operating margin of -1710.51%, and net profit margin of -2074.68%.
Gross Margin-111.89%
Operating Margin-1710.51%
Pretax Margin-2074.68%
Net Profit Margin-2074.68%
EBITDA Margin-1742.02%
EBIT Margin-1794.61%
Analyst Forecast
The average price target for BioNxt Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―